ATE192489T1 - Tumorsuppressor-gen merlin und dessen verwendungen - Google Patents

Tumorsuppressor-gen merlin und dessen verwendungen

Info

Publication number: ATE192489T1
Authority: AT; Austria
Prior art keywords: merlin; tumor suppressor; suppressor gene; diagnosis; treatment
Prior art date: 1993-02-25

Application number

AT94301367T

Other languages

English (en)

Inventor

James A Trofatter

Mia M Maccollin

James F Gusella

Original Assignee

Gen Hospital Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-02-25

Filing date

1994-02-25

Publication date

2000-05-15

1994-02-25 Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp

2000-05-15 Application granted granted Critical

2000-05-15 Publication of ATE192489T1 publication Critical patent/ATE192489T1/de

Links

108700025716 Tumor Suppressor Genes Proteins 0.000 title 1
102000044209 Tumor Suppressor Genes Human genes 0.000 title 1
241000272186 Falco columbarius Species 0.000 abstract 4
206010028980 Neoplasm Diseases 0.000 abstract 2
238000003745 diagnosis Methods 0.000 abstract 2
208000002761 neurofibromatosis 2 Diseases 0.000 abstract 2
208000022032 neurofibromatosis type 2 Diseases 0.000 abstract 2
108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
239000013598 vector Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oncology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT94301367T 1993-02-25 1994-02-25 Tumorsuppressor-gen merlin und dessen verwendungen ATE192489T1 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US2203493A	1993-02-25	1993-02-25
US2606393A	1993-03-04	1993-03-04
US10880893A	1993-08-19	1993-08-19
US08/171,718 US5707863A (en)	1993-02-25	1993-12-22	Tumor suppressor gene merlin

Publications (1)

Publication Number	Publication Date
ATE192489T1 true ATE192489T1 (de)	2000-05-15

Family

ID=27487063

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94301367T ATE192489T1 (de)	1993-02-25	1994-02-25	Tumorsuppressor-gen merlin und dessen verwendungen

Country Status (10)

Country	Link
US (2)	US5707863A (de)
EP (1)	EP0613945B1 (de)
JP (1)	JPH07143884A (de)
AT (1)	ATE192489T1 (de)
CA (1)	CA2115404A1 (de)
DE (1)	DE69424209T2 (de)
DK (1)	DK0613945T3 (de)
ES (1)	ES2148283T3 (de)
GR (1)	GR3034057T3 (de)
PT (1)	PT613945E (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5578462A (en) *	1994-01-10	1996-11-26	Bristol-Myers Squibb Company	NF2 isoforms
AU2456397A (en) *	1996-04-12	1997-11-07	Muro Pharmaceutical, Inc.	Isolated and cloned mast cell 78 kda phosphoprotein (mast cell degranulation inhibitory agent) and use thereof
GB9812674D0 (en) *	1998-06-12	1998-08-12	Central Manchester Healthcare	Nucleic acids
US7053200B1 (en)	1999-06-01	2006-05-30	Baylor College Of Medicine	Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
DK1471926T3 (da)	1999-06-01	2011-02-28	Baylor College Medicine	Sammensætninger og fremgangsmåder til terapeutisk anvendelse af en atonal-associeret sekvens
AU6181300A (en) *	1999-07-29	2001-02-19	Helix Research Institute	Liver cancer-associated genes
AU2953201A (en) *	2000-01-20	2001-07-31	Genome Therapeutics Corporation	Rapid determination of gene structure using cdna sequence
ES2291246T3 (es) *	2000-06-27	2008-03-01	Von Recklinghausen Gesellschaft E.V.	Procedimiento para adquirir datos para el diagnostico presintomatico o prenatal de neurofribromatosis del tipo 1.
US20040014699A1 (en) *	2002-07-18	2004-01-22	Isis Pharmaceuticals, Inc.	Antisense modulation of PTPRM expression
US20040249023A1 (en) *	2003-01-17	2004-12-09	Stoffer James O.	Compounds for corrosion resistant primer coatings and protection of metal substrates
CA2862580A1 (en) *	2011-10-28	2013-05-02	Millennium Pharmaceuticals, Inc.	Biomarkers of response to nae inhibitors
TWI710635B (zh)	2014-10-09	2020-11-21	美商珍維克公司	編碼人類無調同源物-1(hath1)之腺病毒載體
CN110846309B (zh) *	2018-08-20	2023-03-24	中国农业科学院兰州兽医研究所	用于鉴定多房棘球绦虫引物对、引物探针组以及他们的应用
AU2022257000A1 (en) *	2021-04-14	2023-11-30	Nicole Christine HENWOOD	Materials and methods for neurofibromin 2/merlin (nf2) gene therapy
WO2022261209A1 (en) *	2021-06-08	2022-12-15	Nf2 Therapeutics, Inc.	Compositions and methods for treating neurofibromatic disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0448650A4 (en) *	1989-02-01	1992-05-13	The General Hospital Corporation	Herpes simplex virus type i expression vector
WO1993003743A1 (en) *	1991-08-16	1993-03-04	The General Hospital Corporation	Method of gene delivery to post-mitotic cells
US5578462A (en) *	1994-01-10	1996-11-26	Bristol-Myers Squibb Company	NF2 isoforms

1993
- 1993-12-22 US US08/171,718 patent/US5707863A/en not_active Expired - Lifetime
1994
- 1994-02-10 CA CA002115404A patent/CA2115404A1/en not_active Abandoned
- 1994-02-24 JP JP6026416A patent/JPH07143884A/ja active Pending
- 1994-02-25 EP EP94301367A patent/EP0613945B1/de not_active Expired - Lifetime
- 1994-02-25 PT PT94301367T patent/PT613945E/pt unknown
- 1994-02-25 DE DE69424209T patent/DE69424209T2/de not_active Expired - Fee Related
- 1994-02-25 AT AT94301367T patent/ATE192489T1/de not_active IP Right Cessation
- 1994-02-25 DK DK94301367T patent/DK0613945T3/da active
- 1994-02-25 ES ES94301367T patent/ES2148283T3/es not_active Expired - Lifetime
1995
- 1995-06-07 US US08/478,087 patent/US6077685A/en not_active Expired - Lifetime
2000
- 2000-07-28 GR GR20000401749T patent/GR3034057T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69424209D1 (de)	2000-06-08
EP0613945A3 (de)	1996-01-17
GR3034057T3 (en)	2000-11-30
EP0613945A2 (de)	1994-09-07
DK0613945T3 (da)	2000-09-25
JPH07143884A (ja)	1995-06-06
DE69424209T2 (de)	2001-01-25
CA2115404A1 (en)	1994-08-26
EP0613945B1 (de)	2000-05-03
US5707863A (en)	1998-01-13
ES2148283T3 (es)	2000-10-16
PT613945E (pt)	2000-10-31
US6077685A (en)	2000-06-20

Legal Events

Date	Code	Title	Description
2000-10-15	UEP	Publication of translation of european patent specification
2003-11-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE231551T1 (de)	2003-02-15	Huntingtin-dna, protein und verwendung
DE69424209D1 (de)	2000-06-08	Tumorsuppressor-Gen Merlin und dessen Verwendungen
AU1064188A (en)	1988-08-04	Precursor protein of APC polypeptide, DNA coding for this and diagnostic use of the DNA and of the protein
CY1111950T1 (el)	2015-11-04	32 ανθρωπινες εκκρινομενες πρωτεϊνες
CA2184908A1 (en)	1995-09-14	Human osteoclast-derived cathepsin
WO1998040483A3 (en)	1998-11-19	28 human secreted proteins
NO961639L (no)	1996-06-24	Rekombinant adenovirusvektor og fremgangsmåte for anvendelse derav
WO1998031800A3 (en)	1998-11-26	Human proteins
WO1998045712A3 (en)	1998-12-03	20 human secreted proteins
WO2001036432A3 (en)	2002-05-10	18 human secreted proteins
WO1999047674A3 (en)	2000-01-20	Compounds and methods for therapy and diagnosis of lung cancer
CA2234263A1 (fr)	1998-02-05	Composition pharmaceutique contre les tumeurs et infections a papillomavirus
WO2001012776A3 (en)	2001-08-30	18 human secreted proteins
WO2000017222A8 (en)	2000-07-06	31 human secreted proteins
WO2000077026A8 (en)	2001-03-29	49 human secreted proteins
NZ335633A (en)	2000-10-27	Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
AU3390995A (en)	1996-03-29	Novel implant and novel vector for the treatment of acquired diseases
WO2001012775A8 (en)	2001-12-06	25 human secreted proteins
WO2000058339A3 (en)	2002-05-10	50 human secreted proteins
WO2000061624A8 (en)	2001-03-08	48 human secreted proteins
WO2000043495A3 (en)	2000-12-28	33 human secreted proteins
WO2003052377A9 (en)	2013-10-24	41 human secreted proteins
WO2000061596A8 (en)	2002-06-20	50 human secreted proteins
WO2002026931A3 (en)	2004-03-04	71 human secreted proteins
EP1538161A3 (de)	2005-06-15	32 humane sekretierte Proteine